We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYL icon
101
Xylem
XYL
$28.5B
$15M 0.23%
224,384
+48,869
+28% +$3.38M
NKTR icon
102
Nektar Therapeutics
NKTR
$2.39B
$14.7M 0.23%
29,747
+500
+2% +$302K
TAL icon
103
TAL Education Group
TAL
$5.71B
$14.5M 0.22%
543,000
-103,500
-16% -$2.75M
BEN icon
104
Franklin Resources
BEN
$16.9B
$14.5M 0.22%
488,256
+11,492
+2% +$353K
VMW
105
DELISTED
VMware, Inc
VMW
$14.5M 0.22%
105,523
+44,999
+74% +$6.8M
XLNX
106
DELISTED
Xilinx Inc
XLNX
$14.4M 0.22%
168,649
-1,517
-0.9% -$127K
TSLA icon
107
Tesla
TSLA
$1.24T
$14.3M 0.22%
644,685
+46,200
+8% +$994K
DFS
108
DELISTED
Discover Financial Services
DFS
$14.3M 0.22%
241,839
-2,922
-1% -$202K
SLB icon
109
SLB Ltd
SLB
$77.8B
$14.2M 0.22%
392,458
+34,258
+10% +$1.69M
AZUL
110
DELISTED
Azul
AZUL
$13.9M 0.21%
+501,000
New +$12.2M
PTCT icon
111
PTC Therapeutics
PTCT
$6.37B
$13.8M 0.21%
402,523
+77,000
+24% +$2.77M
SRPT icon
112
Sarepta Therapeutics
SRPT
$1.66B
$13.8M 0.21%
126,100
+3,000
+2% +$375K
TXN icon
113
Texas Instruments
TXN
$255B
$13.6M 0.21%
143,669
-28,806
-17% -$2.79M
IONS icon
114
Ionis Pharmaceuticals
IONS
$9.35B
$13.5M 0.21%
249,200
+49,000
+24% +$2.5M
SPLK
115
DELISTED
Splunk Inc
SPLK
$13.4M 0.21%
128,222
-24,206
-16% -$2.45M
TRV icon
116
Travelers Companies
TRV
$80.8B
$13.3M 0.2%
111,104
+18,197
+20% +$2.28M
MNST icon
117
Monster Beverage
MNST
$91.4B
$13.2M 0.2%
537,542
+43,650
+9% +$1.19M
ITUB icon
118
Itaú Unibanco
ITUB
$91.3B
$13.2M 0.2%
1,981,356
+607,422
+44% +$3.9M
MCD icon
119
McDonald's
MCD
$188B
$13.1M 0.2%
73,915
-14,436
-16% -$2.56M
IMMU
120
DELISTED
Immunomedics Inc
IMMU
$12.8M 0.2%
896,376
-869,124
-49% -$17.3M
BDX icon
121
Becton Dickinson
BDX
$43.1B
$12.8M 0.2%
58,138
+515
+0.9% +$120K
TIF
122
DELISTED
Tiffany & Co.
TIF
$12.5M 0.19%
154,985
+135,630
+701% +$13.8M
SBUX icon
123
Starbucks
SBUX
$118B
$12.5M 0.19%
193,551
+13,440
+7% +$841K
DE icon
124
Deere & Co
DE
$170B
$12.3M 0.19%
82,760
+57,658
+230% +$8.44M
TECH icon
125
Bio-Techne
TECH
$11.2B
$12.2M 0.19%
337,956
+15,156
+5% +$633K
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.